Dapagliflozin dramatically increased urinary glucose excretion and the urinary glucose/creatinine ratio (Supplementary Table A5),as expected from its mechanism of action.Dapagliflozin-induced glucose excretion remained elevated and constant from
week 12 to 52, showing no sign of diminished activity during this period (Supplementary Fig. A3).